OBJECTIVE: To determine the extent of glucocorticoid counter-regulatory control in the slimming action of oleoylestrone. DESIGN: Control and adrenalectomized rats were subjected to a seven-day treatment with 3.5 mmolakgad oleoylestrone in liposomes injected i.v. continuously by implanted osmotic minipumps. SUBJECTS: Sham-operated control and adrenalectomized lean Zucker rats. MEASUREMENTS: Body weight and food intake; plasma glucose, urea, insulin, leptin and corticosterone; liver glycogen. RESULTS: Treatment with oleoyl-estrone resulted in decreases in body weight and in food intake, as well as in circulating glucose, insulin and leptin. Combined adrenalectomy and oleoyl-estrone treatment resulted in a loss of almost 15% body weight in only seven days, with a severe drop in circulating glucose and insulin, almost total disappearance of plasma leptin and liver glycogen and a 3-fold rise in circulating urea. Food intake decreased sharply, which resulted in the exhaustion of energy reserves. CONCLUSION: The results presented here, strongly support the hypothesis that glucocorticoids play an important role in the modulation of oleoyl-estrone-induced imbalance of energy intake and expenditure. The large effect of oleoyl-estrone on glucose, glycogen-and protein-derived (urea levels) energy in adrenalectomized rats, provides more evidence for the assumed protective role of glucocorticoids against the oleoyl-estrone-induced net loss of energy reserves. The results also show the powerful destabilizing effects of unchecked oleoyl-estrone on energy balance. and cafeteria-obese 9 rats, the loss of fat being dosedependent. 7 In humans, both plasma leptin 10 and oleoyl-estrone 11 are correlated with their fat mass. Chronic administration of oleoyl-estrone in liposomes induces a decrease in leptin production and concentrations, as well as a transient rise in plasma glucocorticoid concentrations, 12 with only limited increases in hypothalamic CRH.
Introduction
Body weight control is a complex process involving several overlapping subsystems that control food intake, thermogenesis and fat deposition. Recent studies have shown the direct involvement of leptin, a protein synthesized by white adipose tissue (WAT), 1 which modulates food intake 2, 3 and energy expenditure 1 through its action on the hypothalamus. It also modulates insulin function 4 and thermogenesis. 5 It has been postulated that both leptin 1 and oleoyl-estrone 6 are ponderostat signals. Pharmacological doses of oleoyl-estrone in liposomes have been found to cause weight loss in normal, 6, 7 genetically obese 8 and cafeteria-obese 9 rats, the loss of fat being dosedependent. 7 In humans, both plasma leptin 10 and oleoyl-estrone 11 are correlated with their fat mass. Chronic administration of oleoyl-estrone in liposomes induces a decrease in leptin production and concentrations, as well as a transient rise in plasma glucocorticoid concentrations, 12 with only limited increases in hypothalamic CRH. 13 Glucocorticoids protect the body fat stores by counter-regulating the effects of lipolytic agents. 14 High cortisol or corticosterone levels are associated with the maintenance of body fat reserves and obesity, as well as insulin resistance. 15 The increase in glucocorticoids contributes to the down-regulation of receptors when thermogenesis is stimulated by adrenergic agonists. 16 Adrenalectomy may prevent the development of some types of obesity, 17 but not all, 18 and it may affect fat accumulation of the already obese. 19 The action of glucocorticoids is further modulated by corticosterone binding globulin (CBG), a protein synthesized by liver and other tissues. 20 Most circulating glucocorticoid is bound to plasma CBG. 21 The expression and levels of CBG are controlled by glucocorticoids. 22 Its main role is probably to compete with cell receptors for the available hormone, thus acting as a modulator of the amount of hormone that reaches the cell binding sites. 23 The obese often show enhanced sensitivity to glucocorticoids, 24 and they maintain high circulating levels of cortisol (humans) 24 or corticosterone (rodents) 25 , due to alterations in the activity of the hypothalamo-pituitary-adrenal (HPA) axis. 26 The continued effects of this higher glucocorticoid load on the obese, result in altered carbohydrate (CHO) and lipid metabolism. 27 Many of these effects are mediated through the WAT, a key organ in the control of energy partition 28 and, at the same time, the main target for lipid storage induced by insulin.
14 Glucocorticoids also affect the response of WAT to catecholamines 29 and insulin, 30 eliciting the secretion of leptin 31 as a counter-regulatory hormone. In the present study, our aim was to determine whether glucocorticoids also play a role in the counter-regulatory control of the weight loss action of oleoyl-estrone. To this end we studied the effects of this ester in adrenalectomized rats, that is, under conditions in which glucocorticoids could not block the overall lipolytic effect of oleoyl-estrone.
Materials and methods
Twelve-week-old Zucker lean (Faa?) female rats from Charles River (Wilmington, MA, USA) stock weighing 170 ± 220 g were used. The rats were maintained under standard conditions of temperature (22 ± 23 C), humidity (65 ± 75%) and light cycle (lights on from 08.00 ± 20.00 h). They were fed ad libitum with standard chow pellets (B&K, Sant Vicent dels Horts, Spain) and tap water.
In relation to adrenal function, the rats were divided into four groups: sham-operated controls (SO), shamoperated and oleoyl-estrone-treated (SO-OE), adrenalectomized (ADX) and adrenalectomized treated with oleoyl-estrone (ADX-OE). The SO rats were anaesthetized with ethyl ether, then two incisions 1 cm long were cut in the back, down to the kidneys; the wound was then closed, stitched and left to heal. The adrenalectomized (ADX) rats were treated in the same way, but both adrenal glands were cut out prior to stitching; for this group, tap water was replaced with a 9 gal NaCl solution, to partially counter the lack of mineralocorticoid production.
Oleoyl-estrone was synthesized and incorporated into liposomes to produce the Merlin-2 preparation as previously described 6, 32 ; a standard dose of 3.5 mmoladakg of oleoyl-estrone was used. This dose was in the lower range of the amount of Merlin-2 that provokes maximal weight loss effects in normal rats. 7 Alzet osmotic minipumps (model 2ML2; Alza, Palo Alto, CA, USA) that provided a rate of release of 5 mlah, were ®lled with either Merlin-2 or hormonefree liposomes. Seven days after the rats were adrenalectomized or sham-operated, the minipumps were surgically implanted under the skin on the back of the rats, anaesthetized with ethyl ether. The minipumps were connected, using a short PE10 polyethylene tube (Beckton Dickinson, Parsipanny, NJ, USA), into the left jugular vein. The rats were weighed daily, and their food and water a saline consumption recorded.
Treatment was continued for seven days; the animals were then killed by decapitation (between 08.30 ± 09.30 h) and exsanguinated. Utmost care was taken not to disturb the animals (kept in individual cages) and to kill them as swiftly and painlessly as possible. Immediately after death, liver samples were removed, frozen in liquid nitrogen and preserved at 7 80 C until processed for glycogen 33, 34 and lipid 35 content measurement. Blood was collected in heparinized beakers, aliquots were deproteinized with perchloric acid and used for glucose estimation. 36 The rest of the blood was centrifuged in polypropylene tubes to obtain plasma, which was stored at 7 20 C. Plasma samples were used for the measurement of insulin 37 using a rat insulin kit (Amersham, Amersham, UK), corticosterone with labelled hormone from NEN (Bad Mannheim, Germany) and polyclonal antibodies from Sigma (C-8784; St Louis, MO, USA). Leptin was measured using a speci®c rat leptin radioimmunoassay (RIA) kit (RL-83K from Linco, St Charles, MO, USA). Plasma was also used to determine the concentration of urea with a ready-to-use kit (B 8035 from Menarini, Milano, Italy).
Comparisons between groups were done using standard ANOVA programs and the Student's t test; the limit of statistical signi®cance was set at P`0.05. Figure 1 depicts the body weight change in adrenalectomized and sham-operated rats, either treated with oleoyl-estrone in liposomes or with the control liposomes. SO rats increased in weight by 8.1AE 0.9% in seven days, whilst the SO-OE lost 2.5 AE 0.9% (P`0.05 vs SO). ADX rats maintained their weight, increasing only by 2.8AE 1.9% (P`0.05 vs SO), and the ADX-OE lost 16.0AE 0.7% of their initial weight (P`0.05 vs OE and vs ADX).
Results
Food consumption is depicted in Figure 2 . The SO controls increased their food consumption in parallel to their increase in body weight. The ADX group behaved in a similar way, but they consumed less food. Treatment with oleoyl-estrone signi®cantly reduced food consumption in the sham-operated animals (SO-OE) by about 28 ± 29%, but in the ADX-OE group, food consumption dropped markedly, by 52% (day 2) or 73% (day 7) with regard to untreated ADX rats.
The mean saline intake of ADX rats over the sevenday period was 168AE 13 mLakgad, which was higher (P`0.05) than the water consumption of SO controls (113 AE 5 mLakg Á d). The water intake of SO-OE rats was 95AE 9 mLakg Á d, which was not different from that of SO controls. The ADX-OE group saline intake Oleoyl-estrone slimming and adrenalectomy MM Grasa et al was 102AE 10 mLakg Á d, which was only signi®cantly different from the ADX group (P`0.05). Table 1 shows the data concening several indicators of energy metabolism after the seven-day treatment with oleoyl-estrone in liposomes. In SO, treatment resulted in a slight decrease in blood glucose, which was much more marked in the ADX-OE rats. Liver glycogen decreased in all adrenalectomized animals, almost disappearing in the ADX-OE group. Plasma urea was well maintained except in this same group, with levels almost 3-fold higher than in the other groups. On the other hand, liver lipid levels were well maintained irrespective of adrenalectomy or oleoylestrone treatment, in spite of a marked decrease in liver size.
The concentrations of corticosterone, insulin and leptin in adrenalectomized and oleoyl-estrone treated rats are presented in Table 2 . As expected, all adrenalectomized rats showed only residual corticosterone levels. In fact this was a test of the ef®cacy of adrenalectomy, and rats with high corticosterone levels were discarded. Treatment with oleoyl-estrone in liposomes for seven days, did not raise the corticosterone levels of sham-operated rats. However, this treatment decreased insulin concentration, the effects being more marked in adrenalectomized-treated rats, because the ADX animals already had lower insulin concentrations than the SO controls. A similar pattern can be seen with circulating leptin: the concentrations of leptin in the SO-OE rats were almost half those of the SO controls; in ADX rats, the concentrations were also lower than those of SO rats, but the combination of adrenalectomy and oleoyl-estrone treatment (ADX-OE) decreased leptin below the limit of detection of the method used. In fact, only one in nine experimental animals gave a result barely above this limit. ; ADX-OE adrenalectomized rats treated with oleoyl-estrone (n 9). There was a signi®cant effect of time (P 0.024), adrenalectomy (P 0.000) and oleoyl-estrone treatment (P 0.000) as determined with a three-way ANOVA program. 11); SO-OE sham-operated rats treated with oleoyl-estrone (n 10); ADX adrenalectomized controls (n 9); ADX-OE adrenalectomized rats treated with oleoyl-estrone (n 9). There was a signi®cant effect of time (P 0.000), adrenalectomy (P 0.000) and oleoyl-estrone treatment (P 0.000), as determined with a three-way ANOVA program. 
Discussion
The involvement of glucocorticoids in the regulation of metabolic processes has often been studied using adrenalectomy, a situation in which the function of the HPA axis is suspended. In this study, the low corticosterone concentrations observed in the adrenalectomized rats indicated that the surgical procedure was effective. This means that all the counter-regulatory mechanisms, which depend on glucocorticoids and maintain the integrity of fat stores, 14 were no longer able to protect them.
Adrenalectomy affects the energy balance of experimental animals 38 ; it may prevent the onset of some forms of obesity 17 and even revert excess fat deposition. 18 The effects of glucocorticoids on leptin are 2-fold, since they induce leptin production by the WAT 39 and adrenalectomy also strongly potentiates the weight loss effects of leptin. 40 Administration of oleoyl-estrone in liposomes leads to weight loss in rats, 6 greatly affecting the leptin pathway. 12 This effect is not due to modulation of leptin synthesis, since it is observed even in hyperleptinaemic 41 Zucker obese rats, 8 which lack a fully functional leptin receptor. 42, 43 The amounts of¯uid drunk by SO and ADX-OE rats were similar and in the range of previous studies for the same strain 44 and we can assume that their metabolic water contribution (about one third) to the total water budget of the rat was comparable in all groups studied, since total energy consumption was also comparable (either from food consumed and from internal sources) in all groups. These data, suggest that the loss of weight observed in the ADX-OE rats, was not primarily due to a massive water imbalance, but to a severe drainage of body energetic components.
The effects of oleoyl-estrone in liposomes observed here, are comparable to those found in other experimental models, 6, 8, 9 but they are`accelerated' (that is, the percentage of loss of body weight in ADX-OE rats over four or ®ve days, is the same as that observed in normal rats treated for two weeks). The differences between SO-OE and ADX-OE rats are largely due to a synergistic effect of adrenalectomy and oleoyl-estrone treatment and not the simple addition of their separate effects (that is the sum of differences between SO and ADX and, SO and OE-SO).
Oleoyl-estrone treatment produced devastating effects on the energy balance of the adrenalectomized rats, that is, in a condition where the slimming action of oleoyl-estrone could not be counteracted by glucocorticoids. The body weight lost in just one week was higher than the total amount of fat stored in a normal rat, 8 which means that the rats lost not only fat, but also lean tissue. The high urea levels suggest that protein was actively mobilized in a situation when liver glycogen had been totally exhausted and the rat had dif®culty in maintaining blood glucose. The lack of changes in liver lipids may be a consequence of the massive loss of WAT fat combined with a relative scarcity of protein, which is needed to help mobilize this fat in the form of lipoproteins.
The powerful deregulating effects of oleoyl-estrone treatment in adrenalectomized rats were more evident in the lowering of insulin levels, a constant in oleoylestrone treatment, 12 and the low blood glucose. But the most marked effects were found in leptin, which almost disappeared from the plasma. This could be due to the combined inhibitory effect of oleoylestrone on WAT leptin production 12 and the disappearance of WAT, at least of its fat, as induced by oleoyl-estrone 6, 8 ; but it may also be a consequence of the energy imbalance that induced oleoyl-estrone unchecked by glucocorticoids. The marked loss of appetite, as shown by the low energy intake, is a characteristic of oleoyl-estrone treatment, 7 albeit much less marked in rats with functional adrenal glands. In any case, this effect on appetite, again suggests that the control of appetite by this ester is not mediated by leptin. This contrasts with the postulated key role of leptin in the control of food intake 2, 3, 45 and is consistent with a more complex control of energy intake. 46 The loss of appetite could not be explained by adrenalectomy-enhanced secretion 47 of hypothalamic CRH, a powerful anorexigenic agent, 48 since the effects of oleoyl-estrone on hypothalamic CRH are scant (and become nil in Zucker faafa rats) 13 in spite of decreased appetite.
Conclusion
The results presented here, strongly support the hypothesis that glucocorticoids play a key role in the modulation of oleoyl-estrone-induced imbalance Oleoyl-estrone slimming and adrenalectomy MM Grasa et al of energy intake and expenditure. The mobilization of fat reserves, elicited by oleoyl-estrone, is probably hampered by glucocorticoids. The large effects of oleoyl-estrone on glucose, glycogen-and proteinderived (urea levels) energy in adrenalectomized rats, provides further evidence for the assumed protective role of glucocorticoids. It also helps to demonstrate the powerful destabilizing effects of unchecked oleoyl-estrone on the energy balance.
